SEBI Examining The Complaint Against Sun Pharma’s Dilip Shanghvi
SEBI has announced that it is examining the whistleblower complaint against Dilip Shanghvi, CEO and Managing Director of Sun Pharmaceutical Industries. SEBI Chairman Ajay Tyagi...
Download Unicorn Signals App
Powered By EquityPandit
